Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McGill University

$183,620.00

Pathway of proteoglycan degradation in articular cartilage

EF 2009-10

Résumé
Articular cartilage covers the surface of bones in joints, and destruction of articular cartilage is a lasting consequence of arthritis. Cartilage destruction begins with damage to its molecular components, proteoglycan and collagen. Protein-degrading enzymes, proteases, cause cartilage destruction, and matrix metalloproteases, play a major role. Matrix metalloproteases are abundant in cartilage, but are normally present as inactive precursor forms. It is still unclear how this activation occurs, and to what extent it must occur to result in cartilage damage. This proposal is based on the hypothesis that the cells in arthritic cartilage undergo a change in function due to the depletion of proteoglycan by other proteases, which results in the activation of the matrix metalloproteases, so completing proteoglycan degradation and initiating collagen damage and cartilage loss. The work will be performed in tissue culture, where articular cartilage or its cells can be kept alive. The arthritic condition will be mimicked by depleting the cells of their surrounding proteoglycan, and exposing the cultures to the mediators of inflammation present in the arthritic joint. The identity of the matrix metalloproteases being produced will be determined, together with their ability to degrade the proteoglycan. As loss of collagen is an irreversible step in cartilage destruction in arthritis, and loss of the proteoglycan is potentially reversible, an understanding of the mechanisms whereby matrix metalloproteases are activated is an essential prerequisite before therapeutic strategies can be developed to retard, prevent or even reverse cartilage damage. Arthritis and it can occur at any age, but is most commonly associated with the elderly as osteoarthritis which affects 10% of the Canadian population, and therefore the development of new therapeutic strategies will be of major benefit to the health care system.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199508
Name
Mort John S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Pathway of proteoglycan degradation in articular cartilage
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$183,620
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Aggrecan; Cartilage; Cytokine; Extracellular Matrix; Osteoarthritis; Protease
Abstract
Articular cartilage covers the surface of bones in joints, and destruction of articular cartilage is a lasting consequence of arthritis. Cartilage destruction begins with damage to its molecular components, proteoglycan and collagen. Protein-degrading enzymes, proteases, cause cartilage destruction, and matrix metalloproteases, play a major role. Matrix metalloproteases are abundant in cartilage, but are normally present as inactive precursor forms. It is still unclear how this activation occurs, and to what extent it must occur to result in cartilage damage. This proposal is based on the hypothesis that the cells in arthritic cartilage undergo a change in function due to the depletion of proteoglycan by other proteases, which results in the activation of the matrix metalloproteases, so completing proteoglycan degradation and initiating collagen damage and cartilage loss. The work will be performed in tissue culture, where articular cartilage or its cells can be kept alive. The arthritic condition will be mimicked by depleting the cells of their surrounding proteoglycan, and exposing the cultures to the mediators of inflammation present in the arthritic joint. The identity of the matrix metalloproteases being produced will be determined, together with their ability to degrade the proteoglycan. As loss of collagen is an irreversible step in cartilage destruction in arthritis, and loss of the proteoglycan is potentially reversible, an understanding of the mechanisms whereby matrix metalloproteases are activated is an essential prerequisite before therapeutic strategies can be developed to retard, prevent or even reverse cartilage damage. Arthritis and it can occur at any age, but is most commonly associated with the elderly as osteoarthritis which affects 10% of the Canadian population, and therefore the development of new therapeutic strategies will be of major benefit to the health care system.
Competitiondate
201003
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mort, John S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $183,620~ $0~